http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0164959-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-54 |
| filingDate | 1985-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1992-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1992-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0164959-B1 |
| titleOfInvention | Pharmaceutical composition in sustained release unit dose form and process for its preparation |
| abstract | A pharmaceutical composition of a medicament, such as a 5-(pyridinyl)-2(IH) pyridone, in sustained release unit dosage form for oral administration. The composition is in the form of beads within a capsule of gelatin or the like. Each bead comprises an inert particulate core having adhered thereto a coating of particles of the medicament. This coating is in turn surrounded by a sustaining coating of three different polymers with different solubility profiles to allow a sustained release of the medicament both in the low pH environment of the stomach and at a higher pH values prevailing in the intestine. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7863331-B2 |
| priorityDate | 1984-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.